Skip to main content
OpenTrials

Clinical trial condition

Digestive System Neoplasms

Explore clinical trials studying Digestive System Neoplasms. Study availability and eligibility vary by location and protocol.

14,360 public trials 3,273 recruiting studies
Refine in advanced search Browse all conditions

Digestive System Neoplasms trial results

Active, not recruiting

A Study of Atezolizumab With or Without Tiragolumab Following Neoadjuvant Chemoradiotherapy in Participants With Locally Advanced Rectal Cancer

NCT05009069

Conditions
Colorectal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, +9 more
Locations
  • Beijing Cancer Hospital Beijing, China
  • The Sixth Affiliated Hospital of Sun Yat-sen University Guangzhou, China
  • The Second Affiliated Hospital of Zhejiang University School of Medicine Hangzhou, China
  • Zhongshan Hospital Fudan University Shanghai, China
View Trial Details
Active, not recruiting

Study of Durvalumab and Tremelimumab as First-line Treatment in Patients With Advanced Hepatocellular Carcinoma

NCT03298451

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations
  • Research Site Los Angeles, California, United States
  • Research Site Orange, California, United States
  • Research Site San Francisco, California, United States
  • Research Site Washington D.C., District of Columbia, United States
View all 160 locations
View Trial Details
Active, not recruiting

Cisplatin and Etoposide Versus Temozolomide and Capecitabine in Patients With Advanced Poorly Differentiated (G3) Non-Small Cell Gastrointestinal Neuroendocrine Carcinomas

NCT02595424

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Islet Cell, +19 more
Locations
  • Kingman Regional Medical Center Kingman, Arizona, United States
  • Cancer Center at Saint Joseph's Phoenix, Arizona, United States
  • Mercy Hospital Fort Smith Fort Smith, Arkansas, United States
  • CHI Saint Vincent Cancer Center Hot Springs Hot Springs, Arkansas, United States
View all 673 locations
View Trial Details
Active, not recruiting

First in Human Phase1/2a Clinical Trial of Anti-PAUF Monoclonal Antibody PBP1510 in Patients With Pancreatic Cancer

NCT05141149

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations
  • Northwell Health / R.J. Zuckerberg Cancer Center New Hyde Park, New York, United States
  • Monash Health Melbourne, Australia
  • National Cancer Centre Singapore Singapore
  • Hospital Universitario La Paz Madrid, Spain
View Trial Details
Active, not recruiting

Safety and Tolerability of IPH4502 in Patients With Advanced Solid Tumors

NCT06781983

Conditions
Adnexal Diseases, Advanced or Metastatic Solid Tumors, Breast Diseases, +64 more
Locations
  • Massachusetts General Hospital - Boston Boston, Massachusetts, United States
  • John Theurer Cancer Center Hackensack, New Jersey, United States
  • Mount Sinai Tisch Cancer Center New York, United States
  • NEXT Oncology - Dallas Dallas, Texas, United States
View Trial Details
Active, not recruiting

Circulating DNA to Improve Outcome of Oncology PatiEnt. A Randomized Study

NCT04258137

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +22 more
Locations
  • Centre hospitalier de la Côte Basque Bayonne, France
  • Clinique Tivoli-Ducos Bordeaux, France
  • Institut Bergonie Bordeaux, France
  • Polyclinique Bordeaux Nord Aquitaine Bordeaux, France
View Trial Details

Related conditions